Article

Impact of Micro-, Mini- and Multi-Electrode Mapping on Ventricular Substrate Characterisation

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Information image
Average (ratings)
No ratings
Your rating

Abstract

Accurate substrate characterisation may improve the evolving understanding and treatment of cardiac arrhythmias. During substrate-based ablation techniques, wide practice variations exist with mapping via dedicated multi-electrode catheter or conventional ablation catheters. Recently, newer ablation catheter technology with embedded mapping electrodes have been introduced. This article focuses on the general misconceptions of voltage mapping and more specific differences in unipolar and bipolar signal morphology, field of view, signal-to-noise ratio, mapping capabilities (density and resolution), catheter-specific voltage thresholds and impact of micro-, mini- and multi-electrodes for substrate mapping. Efficiency and cost-effectiveness of different catheter types are discussed. Increasing sampling density with smaller electrodes allows for higher resolution with a greater likelihood to record near-field electrical information. These advances may help to further improve our mechanistic understanding of the correlation between substrate and ventricular tachycardia, as well as macro-reentry arrhythmia in humans.

Disclosure:BB has received travel grants, research grants and speaker fees from Biosense Webster, Boston Scientific and Abbott. KZ has received research grants from Biosense Webster. RT has received consulting, travel grants and speaker fees from Abbott.

Received:

Accepted:

Published online:

Correspondence Details:Benjamin Berte, Heart Center, Lucerne Cantonal Hospital, Spitalstrasse, 6000 Lucerne 16, Switzerland. E: Benjamin.Berte@luks.ch

Copyright Statement:

This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

Accurate substrate characterisation is important for depicting scar-related re-entrant tachycardia to optimise ablation targets and strategies. The underlying substrate can be analysed using electrogram (EGM) characteristics, such as low voltage, local abnormal voltage activity (LAVA), evoked potentials or late potentials, conduction analysis in sinus rhythm or differential pacing, or using imaging modalities, such as delayed enhancement MRI (delayed enhancement) CT, PET, histology or a combination of these techniques.2–11 The aim of high-resolution mapping is to obtain histological-level information of the extent and location of abnormal substrate across the myocardial wall to guide and expedite targeted ablation.

Voltage Mapping: Unipolar, Bipolar or Omnipolar Mapping?

Unipolar Recording

A dipole field coming towards the electrode creates a positive deflection, and a wavefront going away from the electrode creates a negative deflection. Although unipolar recordings are the purest direct recordings used to derive bipolar recordings, they are less often used due to their large field of view with less sensitivity for near-field, low-amplitude electrogram components, which also makes them more prone to low frequency artefacts. The duration of the unipolar deflection and amplitude are proportional to the electrode size.

Bipolar Recording

Bipolar recordings are merely the subtraction of two unipolar recordings. Smaller electrodes average over less space, creating a higher BV (or delta) and shorter duration due to a higher slope (dv/dt), because the dipole field falls off quickly. At normal conduction velocities, the wavefront dipole dimension (+ to –) is around 1–3 mm. This leads to a necessary correlation between adequate electrode size and inter-electrode distance. The main advantage of bipolar recordings is far-field rejection, which is further improved with the use of smaller, flatter electrodes with smaller interelectrode distance.12 As a result, higher frequency components are created and visualised, which has become synonymous with near-field recordings. The main disadvantage of bipolar mapping is its wavefront dependency due to the orientation of the relative positioning of the two unipoles to derive the electrogram.13 High-density multi-electrode grid catheters (e.g. HD-32 Grid) allow for simultaneous recordings in multiple orthogonal directions around a small region of tissue, with the ability to select the largest BV. This is possible with equidistant electrode configurations on the HD Grid catheter, which may allow for selection of the bipole pair that aligns most closely to the direction of the activation wavefront.14,15

Omnipolar Technology

Due to these findings, new ways to evaluate centrifugal or centripetal activation are suggested, such as omnipolar technology (OT), independent of the orientation of the wavefront. OT employs multiple electrodes and mathematical models of wave propagation to determine the direction of a traveling wave along the myocardial plane by interrogating its electric field. OT can survey all possible bipolar electrode orientations and can obtain electrode orientation–independent electrograms along the maximal bipolar direction.16

Misconceptions and Difficulties of Substrate Mapping Using Bipolar Voltage Mapping

Several factors influence low BV mapping, such as tissue factors (e.g. healthy or fibrotic tissue and epicardial or myocardial fat), the influence of conduction velocity, fibre orientation and curvature, catheter–tissue relationship (angle of incidence, contact force, orientation in relation to wavefront propagation and tissue oedema), different filter settings and catheter characteristics (Figure 1).12 This review focuses on the impact of catheter characteristics, which include electrode size, shape and interelectrode spacing, and electrochemical factors, such as fractal surfacing, coating and welling.

Catheter Types and Configurations

Substrate mapping can be performed using conventional ablation catheters with a large tip, or using dedicated linear, basket, multi-spline or grid catheters. Recently, novel ablation catheters have been developed with mini- or micro-electrodes embedded in the distal tip electrode. Catheter and electrode design will influence:

  • the amplitude and duration of the local EGM, and therefore, the spatial and temporal resolution of the catheter used;
  • the field of view;
  • the signal-to-noise ratio;
  • the catheter-specific voltage values;
  • the affinity to detect conduction channels and LAVA; and
  • mapping density, and therefore, the efficiency of the catheter used.

Impact of Catheter Characteristics

Electrode Size and Catheter Orientation

Smaller electrodes typically result in sharper (high frequency) and shorter EGM duration. The amplitude of a bipolar electrogram depends on the electrode size, the angle of incidence between the catheter and tissue, and the orientation of the bipole relative to the wavefront propagation. Standard 3.5-mm ablation catheters with larger tip electrodes and wide bipolar spacing can appear more similar to unipolar recordings, depending on the angle of incidence and the distance from the ring electrode to the tissue (Figure 1). The design of most multi-electrode catheters with small electrodes allows for a stable bipolar electrode position parallel to the tissue, thereby reducing the influence of the angle of incidence. Ablation catheters with incorporated micro-electrodes have features of both (Table 1).12 Bipolar voltage (BV) recorded with micro-electrodes are three times larger than BV recorded with conventional electrodes at the same site,17 but similar mean BVs were recorded using OctaRay versus PentaRay.17,18 Computing models and animal data suggest possible limited resolution differences <1 mm of electrode sizes for all catheter types.18,19

Interelectrode Distance

Increased interelectrode distance results in a larger BV amplitude and a loss of spatial resolution to detect LAVA.12,20,21 Both far-field and near-field BVs increase with increased spacing, although near-field increases may be less proportional. The near-field to far-field ratio increases due to predominant far-field rejection with closer spacing. Therefore, smaller spacing, ideally 1–2 mm, results in more optimal resolution. Only very small electrode sizes can be used in tight spacing (<1 mm) to overcome auto-cancellation within a bipole (Table 1).

Impact of Orientation, Size and Spacing on Bipolar Voltage Mapping

Article image

Bipole Orientation

Multi-electrode catheters are highly dependent on the direction of the propagating wavefront relative to the orientation of the bipole pair (Figure 2).12 Depending on the spline orientation or different conduction (sinus rhythm or pacing manoeuvres), different BVs (variation around 30%) are measured, and a significant percentage of around 30% of LAVA are recorded or masked.7,21–23 These variations are most often present in the scar border zone (mixed scar tissue) and with orthogonal bipole activation. This limitation may theoretically be overcome using omnipole mapping or maximal bipolar amplitude mapping (HD wave) with the HD Grid catheter, or by concomitant use of imaging-derived substrate information.14,24 In theory, an incident wavefront that is exactly 90° to both bipoles would result in cancellation. However, in vivo, activation occurs in 3D, and it is unlikely that this scenario is relevant in clinical cases (isoelectric EGM without an intrinsic amplitude).25 Additionally, repeated sampling in a region of interest also overcomes this limitation, as the catheter orientation varies with each manipulation, increasing the probability of detecting a larger local EGM.

Different Catheter Characteristics of the Most Used Catheters

Article image

Customising Voltage Mapping Values Relative to the Recording Catheter

Conventional scar and low BV thresholds (0.5–1.5 mV) were defined by Marschlinski et al., based on mapping with a conventional large-tip electrode.1 The 1.5 mV threshold has been validated in animal models of transmural myocardial infarcts, but the dense scar level of 0.5 mV has been arbitrarily defined.26 Based on the prior findings and comparison with MRI-derived substrate, several authors have suggested specific BV thresholds for each dedicated mapping catheter:

  • PentaRay: 0.2–1 mV or 1.5 mV;
  • Orion: 0.1–1 mV
  • LiveWire: 0.5–1.5 mV; and
  • ablation catheter: 0.5–1.5 mV.20,27,28

As voltage thresholds have only been validated for post-infarct scars, the use of one single threshold is oversimplified. Due to the explanations above, it is likely that, for catheters with smaller electrode sizes and spacings, higher voltage thresholds to identify normal myocardium should be applied. For QDOT MICRO, scar thresholds of unipolar <5.44 mV, bipolar <1.27 mV and mini- or micro-electrodes (MEs) <2.84 mV have been suggested validated by histology in an animal infarct model.29 Whole-heart histology in non-ischaemic cardiomyopathy has highlighted that no specific cutoffs can be found, as fibrosis patterns and architecture are different compared with ischaemic cardiomyopathy, and wall thinning is often absent.30

Catheter Design and Configurations

Multi-electrode Catheters

Different models of dedicated multi-electrode mapping catheters are used: linear versus multi-spline versus grid versus basket catheters with around 0.5–1 mm3 electrode sizes and 2–3 mm interelectrode distances. With all currently available multi-electrode catheters, there is lack of contact force measurement, and the direction of the wavefront influences both electrogram amplitude and duration. Due to their location on the catheter tip (angle between the three bipoles is 60°), ME may at least partly compensate for wavefront influence, as the highest BV is recorded. In recent animal work, the highest recorded ME BV was was able to more adequately detect viable myocardium throughout the ventricular wall in an animal model of reperfused MI, validated by histology, compared to both conventional QDOT MICRO ablation electrodes and PentaRay.31

Examples of Micro- and Multi-electrode Catheters

Article image

A custom-made 112-electrode (2 mm size, 1 mm spacing) endocardial balloon was used by another group to analyse extremely low amplitude potentials in the range of 50–100 μV. They found that decremental evoked potentials (using extra-stimulus testing) were more specific than LAVA potentials to identify the diastolic isthmus during ventricular tachycardia.32

Multi-spline variants of multi-electrode catheters are often arrhythmogenic during endocardial mapping, especially in small and healthy ventricles, and cannot correct for wavefront dependency of voltage, which can be achieved with a grid design. In theory, more accurate entrainment mapping can be performed using multi-electrode catheters due to less output required to capture from small electrodes and sharper EGM recording allowing for more precise measurements of local activation times. The ideal number, spacing and size of the electrodes of such catheters is still under investigation; for example, OctaRay mapping is faster and denser compared to PentaRay mapping, but has similar substrate resolution in a ventricular mapping study (Figure 2).

In the present study we hypothesised a ‘mapping plateau’ with electrode sizes <1 mm, which has been supported by a computational study comparing electrode sizes.18,19 More electrodes can increase mapping speed and density, and smaller sizes and spacing increase spatial resolution and potentially reduce RF time, but their additional impact on ventricular tachycardia non-inducibility or effectiveness is not known.33,34 Their (cost-)efficiency is questionable; although substrate maps can be acquired faster with higher density and better mapping resolution, a separate ablation catheter is still needed (Table 2).35

Mini- and Micro-electrode Catheters

There are currently two ablation catheters with smaller embedded electrodes: IntellaNav MIFI (without contact force, Boston Scientific) and QDOT MICRO (with contact force, Biosense Webster). The three micro-electrodes of the QDOT MICRO are smaller, more distally on the distal electrode located at a 60° angle compared to the three mini-electrodes of the IntellaNav MIFI that are slightly larger, and more proximally located on the electrode at a 90° angle (Table 1 and Figure 2). It is not known if the differences between both have a significant clinical impact. The highest ME BV is depicted to compensate, at least in part, for wavefront influence. Due to their design, they record sharper high-frequency EGMs and higher BVs (Figure 2). Therefore, different voltage thresholds for ME voltage maps are needed. These catheters may be more cost-efficient, as the mapping and ablation features are integrated, but mapping time is likely to be longer. These micro-electrode-embedded catheters could be used to directly check LAVA elimination, without the need for remapping with a multi-electrode mapping catheter, saving time and/or the need for an additional catheter.

The catheters can be used as standalone, but can also be combined with multi-electrode catheters or imaging-derived scar information (Table 2).36

Pros and Cons of Mini- or Micro-electrode and Multi-electrode Catheters

Article image

Combined Fields of View from Mini- or Micro-electrode-embedded Catheters

Article image

Using only ME with a smaller field of view may also present disadvantages with regard to the durability of ablation lesions. In a recent study, radiofrequency applications were immediately terminated just after the rapid (4 seconds) loss of pulmonary vein signals on ME during pulmonary vein isolation. Of importance, reappearance of these micro-EGM signals was observed after 45 minutes’ waiting time, due to reversible oedema. Therefore, micro-EGM can be used to improve the ablation location accuracy, but should not be used to guide ablation duration.

Differences in Fields of View

In a computational model, approximately 90% of the BV amplitude reflects the activation of the closest 1-mm myocardium. Accordingly, voltage mapping data for transmural tissue information need to be interpreted with caution.18 Successful ablation and termination of ventricular tachycardia is sometimes performed in locations without any signal on the distal bipolar EGM of the ablation electrode. The new ablation catheters mentioned above combine two different fields of view (Figure 3). This could lead to more detailed analysis of the subendocardially located tissue in contact using ME combined with a deeper analysis within the myocardial wall using conventional electrodes. In a recently published animal study, the accuracy in correctly identifying the histological substrate increased to 93% using ME in combination with conventional unipolar voltage mapping when using the QDOT MICRO catheter.17

Specific problems concerning the field of view include:

  • The detection of intramural scar covered by layers of viable myocardium may be detected by pacing manoeuvres measuring transseptal conduction time >40 ms and EGM duration >95 ms.37
  • Epicardial fat mimicking scar due to attenuation of voltage, but with often shorter EGM duration and less deflections compared to scar.38
  • Loss of micro-EGM on ME due to oedema can be interpreted in the same way.
  • Thin-layered epicardial scar obscured by the underlying viable myocardium.39 Contrast-enhanced cardiovascular magnetic resonance can be helpful to identify intramural scars, and multi-detector CT can provide detailed information on epicardial fat thickness allowing for better interpretation of the local EGM amplitude (Figure 4).40

Problems with Field of View

Article image

Example of Difference in Field of View

Article image

Difference in Signal-to-noise Ratio

Flat electrodes are less influenced by far field than cylindric or thicker electrodes, as they collect information further away from the tissue in contact. Fractal surface modification of the electrodes is sometimes used to obtain a small geometric footprint to minimise artefact interaction with multiple wavefronts. However, these fractals have high-electrode-tissue impedance, which increases the coupling of electromagnetic noise sources. Therefore, surface enhancements (e.g. Orion catheter with iridium oxide coating) can be used to decrease electrode-tissue impedance by dramatically increasing the active micro-surface area. By design, micro-electrodes have an excellent signal-to-noise ratio, if lab conditions are optimal.

Even with these enhancements, inherent noise and artefacts may be seen using micro- and mini-electrode mapping. Operator experience is required to recognise the spectrum of artefacts (artefacts from valves, papillary muscles, catheter movement or poor contact), filter setting dependency, irrigation before and during ablation and electrochemical dirt on the electrodes, and potential solutions to improve signal quality (e.g. high-output pacing through the recording electrodes). Improved tissue contact increases the impedance and improves the signal quality.

Distinguishing Near Field from Far Field

While it is important to distinguish near field from far field, a clear uniform definition is not available. In case of poorly coupled electrograms, the two or more components may all arise from near-field activation (double near field). With higher mapping resolution and limited field of view, greater detection and recording of near-field activity results. ME often generate sharper, larger signals with both higher spatial and temporal resolution compared with conventional electrodes. This can help to detect thin layers of viable myocardium.7 Examples of differences in field of view are given in Figure 5.

Comparing Catheters

Due to all of the abovementioned factors, it is important to understand the influence of the catheter design and the catheter–tissue interaction, and not only focus on single aspects, such as electrode size or interelectrode spacing. Bipole and catheter orientation, different filter settings, catheter noise, contact and contact force feedback contribute to EGM recordings. Therefore, operators should be familiar with the specific details of the catheter in use, including number of electrodes, electrode sizes, spacings and noise levels to understand the catheter-specific pitfalls. Table 1 summarises the important variations across diagnostic and ablation catheter configurations that influence the determination of voltage thresholds and the ability to detect near-field electrical recordings.

Conclusion

To understand substrate characterisation using specific catheters, knowledge of the impact of catheter design, bipole configurations and recording methods is critical. All electrograms recorded within a given substrate are subject to the size, spacing and orientation of recording electrodes relative to the wavefront. However, a gold standard does not currently exist. Increasing sampling density with smaller electrodes allows for higher resolution with a greater likelihood to record near-field electrical information, which has been demonstrated to be useful during sinus rhythm and ventricular tachycardia. These advances may help to further improve our mechanistic understanding of the correlation between substrate and ventricular tachycardia, as well as the characteristics of human re-entry.

Clinical Perspective

  • Physicians should be aware of fundamental misconceptions about voltage mapping and the impact of various electrode sizes and configurations on electro-anatomical mapping.
  • Catheter-specific voltage values should be used for accurate substrate detection and depiction.
  • The use of conventional ablation catheters without additional imaging techniques or mapping electrode information is often insufficient for substrate recognition.

References

  1. Marchlinski FE, Callans DJ, Gottlieb CD, et al. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000;101:1288–96.
    Crossref | PubMed
  2. Jais P, Maury P, Khairy P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation 2012;125:2184–96.
    Crossref | PubMed
  3. de Riva M, Naruse Y, Ebert M, et al. Targeting the hidden substrate unmasked by right ventricular extrastimulation improves ventricular tachycardia ablation outcome after myocardial infarction. JACC Clin Electrophysiol 2018;4:316–27.
    Crossref | PubMed
  4. Porta-Sanchez A, Jackson N, Lukac P, et al. Multicenter study of ischemic ventricular tachycardia ablation with decrement-evoked potential (DEEP) mapping with extra stimulus. JACC Clin Electrophysiol 2018;4:307–15.
    Crossref | PubMed
  5. Vergara P, Trevisi N, Ricco A, et al. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation. J Cardiovasc Electrophysiol 2012;23:621–7.
    Crossref | PubMed
  6. Anter E, Kleber AG, Rottmann M, et al. Infarct-related ventricular tachycardia: redefining the electrophysiological substrate of the isthmus during sinus rhythm. JACC Clin Electrophysiol 2018;4:1033–48.
    Crossref | PubMed
  7. Tung R, Josephson ME, Bradfield JS, et al. Directional Influences of ventricular activation on myocardial scar characterization: voltage mapping with multiple wavefronts during ventricular tachycardia ablation. Circ Arrhythm Electrophysiol 2016;9:e004155.
    Crossref | PubMed
  8. Jauregui B, Soto-Iglesias D, Penela D, et al. Follow-up after myocardial infarction to explore the stability of arrhythmogenic substrate: the Footprint study. JACC Clin Electrophysiol 2020;6:207–18.
    Crossref | PubMed
  9. Takigawa M, Duchateau J, Sacher F, et al. Are wall thickness channels defined by computed tomography predictive of isthmuses of postinfarction ventricular tachycardia? Heart Rhythm 2019;16:1661–8.
    Crossref | PubMed
  10. Esposito A, Palmisano A, Antunes S, et al. Cardiac CT With delayed enhancement in the characterization of ventricular tachycardia structural substrate: relationship between CT-segmented scar and electro-anatomic mapping. JACC Cardiovasc Imaging 2016;9:822–32.
    Crossref | PubMed
  11. Duell J, Dilsizian V, Smith M, et al. Nuclear imaging guidance for ablation of ventricular arrhythmias. Curr Cardiol Rep 2016;18:19.
    Crossref | PubMed
  12. Josephson ME, Anter E. Substrate mapping for ventricular tachycardia: assumptions and misconceptions. JACC Clin Electrophysiol 2015;1:341–52.
    Crossref | PubMed
  13. Anter E, Josephson ME. Bipolar voltage amplitude: what does it really mean? Heart Rhythm 2016;13:326–7.
    Crossref | PubMed
  14. Jiang R, Beaser AD, Aziz Z, et al. High-density grid catheter for detailed mapping of sinus rhythm and scar-related ventricular tachycardia: comparison with a linear duodecapolar catheter. JACC Clin Electrophysiol 2020;6(3):311–23.
    Crossref | PubMed
  15. Takigawa M, Relan J, Martin R, et al. Effect of bipolar electrode orientation on local electrogram properties. Heart Rhythm 2018;15:1853–61.
    Crossref | PubMed
  16. Magtibay K, Masse S, Asta J, et al. Physiological assessment of ventricular myocardial voltage using omnipolar electrograms. J Am Heart Assoc 2017;6:e006447.
    Crossref | PubMed
  17. Glashan CA, Tofig BJ, Tao Q, et al. Multisize electrodes for substrate identification in ischemic cardiomyopathy: validation by integration of whole heart histology. JACC Clin Electrophysiol 2019;5:1130–40.
    Crossref | PubMed
  18. Barkagan M, Sroubek J, Shapira-Daniels A, et al. A novel multielectrode catheter for high-density ventricular mapping: electrogram characterization and utility for scar mapping. Europace 2020;22:440–9.
    Crossref | PubMed
  19. Stinnett-Donnelly JM, Thompson N, Habel N, et al. Effects of electrode size and spacing on the resolution of intracardiac electrograms. Coron Artery Dis 2012;23:126–32.
    Crossref | PubMed
  20. Tung R, Kim S, Yagishita D, et al. Scar voltage threshold determination using ex vivo magnetic resonance imaging integration in a porcine infarct model: influence of interelectrode distances and three-dimensional spatial effects of scar. Heart Rhythm 2016;13:1993–2002.
    Crossref | PubMed
  21. Takigawa M, Relan J, Kitamura T, et al. Impact of Spacing and orientation on the scar threshold with a high-density grid catheter. Circ Arrhythm Electrophysiol 2019;12:e007158.
    Crossref | PubMed
  22. Berte B, Relan J, Sacher F, et al. Impact of electrode type on mapping of scar-related VT. J Cardiovasc Electrophysiol 2015;26:1213–23.
    Crossref | PubMed
  23. Tschabrunn CM, Roujol S, Dorman NC, et al. High-resolution mapping of ventricular scar: comparison between single and multielectrode catheters. Circ Arrhythm Electrophysiol 2016;9:e003841.
    Crossref | PubMed
  24. Proietti R, Adlan AM, Dowd R, et al. Enhanced ventricular tachycardia substrate resolution with a novel omnipolar high-density mapping catheter: the omnimapping study. J Interv Card Electrophysiol 2020;58:355–62.
    Crossref | PubMed
  25. Tung R, Raiman M, Liao H, et al. Simultaneous endocardial and epicardial delineation of 3D reentrant ventricular tachycardia. J Am Coll Cardiol 2020;75:884–97.
    Crossref | PubMed
  26. Reddy VY, Wrobleski D, Houghtaling C, et al. Combined epicardial and endocardial electroanatomic mapping in a porcine model of healed myocardial infarction. Circulation 2003;107:3236–42.
    Crossref | PubMed
  27. Nührich JM, Kaiser L, Akbulak RO, et al. Substrate characterization and catheter ablation in patients with scar-related ventricular tachycardia using ultra high-density 3-D mapping. J Cardiovasc Electrophysiol 2017;28:1058–67.
    Crossref | PubMed
  28. Viswanathan K, Mantziari L, Butcher C, et al. Evaluation of a novel high-resolution mapping system for catheter ablation of ventricular arrhythmias. Heart Rhythm 2017;14:176–83.
    Crossref | PubMed
  29. Sramko M, Abdel-Kafi S, van der Geest RJ, et al. New adjusted cutoffs for “normal” endocardial voltages in patients with post-infarct LV remodeling. JACC Clin Electrophysiol 2019;5:1115–26.
    Crossref | PubMed
  30. Glashan CA, Androulakis AFA, Tao Q, et al. Whole human heart histology to validate electroanatomical voltage mapping in patients with non-ischaemic cardiomyopathy and ventricular tachycardia. Eur Heart J 2018;39:2867–75.
    Crossref | PubMed
  31. Glashan CA, Zeppenfeld K et al. Mini- micro- and conventional electrodes: an in-vivo electrophysiology and ex-vivo histology head-to-head comparison. JACC Clin Electrophysiol 2020; epub ahead of press.
    Crossref
  32. Jackson N, Gizurarson S, Viswanathan K, et al. Decrement evoked potential mapping: basis of a mechanistic strategy for ventricular tachycardia ablation. Circ Arrhythm Electrophysiol 2015;8:1433–42.
    Crossref | PubMed
  33. Kitamura T, Martin CA, Vlachos K, et al. Substrate mapping and ablation for ventricular tachycardia in patients with structural heart disease: how to identify ventricular tachycardia substrate. J Innov Card Rhythm Manag 2019;10:3565–80.
    Crossref | PubMed
  34. Acosta J, Penela D, Andreu D, et al. Multielectrode vs. point-by-point mapping for ventricular tachycardia substrate ablation: a randomized study. Europace 2018;20:512–9.
    Crossref | PubMed
  35. Yamashita S, Cochet H, Sacher F, et al. Impact of new technologies and approaches for post-myocardial infarction ventricular tachycardia ablation during long-term follow-up. Circ Arrhythm Electrophysiol 2016;9:e003901.
    Crossref | PubMed
  36. Soto-Iglesias D, Penela D, Jauregui B, et al. Cardiac magnetic resonance-guided ventricular tachycardia substrate ablation. JACC Clin Electrophysiol 2020;6:436–47.
    Crossref | PubMed
  37. Betensky BP, Kapa S, Desjardins B, et al. Characterization of trans-septal activation during septal pacing: criteria for identification of intramural ventricular tachycardia substrate in nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol 2013;6:1123–30.
    Crossref | PubMed
  38. Tung R, Nakahara S, Ramirez R, et al. Distinguishing epicardial fat from scar: analysis of electrograms using high-density electroanatomic mapping in a novel porcine infarct model. Heart Rhythm 2010;7:389–95.
    Crossref | PubMed
  39. Berte B, Sacher F, Cochet H, et al. Postmyocarditis ventricular tachycardia in patients with epicardial-only scar: a specific entity requiring a specific approach. J Cardiovasc Electrophysiol 2015;26:42–50.
    Crossref | PubMed
  40. Piers SR, van Huls van Taxis CFB, Tao Q, et al. Epicardial substrate mapping for ventricular tachycardia ablation in patients with non-ischaemic cardiomyopathy: a new algorithm to differentiate between scar and viable myocardium developed by simultaneous integration of computed tomography and contrast-enhanced magnetic resonance imaging. Eur Heart J 2013;34:586–96.
    Crossref | PubMed